Ksenija Jovanovic, Ranko Trailovic, Magnus Jonsson, Laura Capoccia, Franco Grego, Sanja Stankovic, Predrag Stevanovic, Igor Koncar
{"title":"The Value of Troponin Measurement in Carotid Revascularization: A Scoping Review.","authors":"Ksenija Jovanovic, Ranko Trailovic, Magnus Jonsson, Laura Capoccia, Franco Grego, Sanja Stankovic, Predrag Stevanovic, Igor Koncar","doi":"10.1177/15266028231179874","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>Patients undergoing carotid endarterectomy (CEA) or carotid artery stenting (CAS) are at substantially increased risk of short-term and long-term cardiac complications. Still, the role of perioperative troponin in predicting cardiac events remains unclear. The objective was to systematically summarize the existing evidence on the topic and provide directions for further research.</p><p><strong>Materials and methods: </strong>Studies that examined perioperative troponin values and its association with myocardial injury, and/or myocardial infarction (MI), and/or major adverse cardiac events (MACE) and postoperative mortality in exclusively CEA/CAS patients, published in English until March 15, 2022, were retrieved through a systematic search of MEDLINE and Web of Science. The study selection process was independently performed by 2 authors, while the third researcher resolved disagreements.</p><p><strong>Results: </strong>Four studies with 885 participants met the inclusion criteria. Age, chronic kidney disease, presentation of carotid disease, type of closure (primary closure/venous patch/Dacron/polytetrafluoroethylene patch), coronary artery disease, chronic heart failure, and the long-term use of calcium channel blockers represent risk factors for troponin elevation, which occurred in 11% to 15.3%. Myocardial infarction and MACE occurred in 23.5% to 40%, that is, 26.5% of patients with troponin elevation, respectively, during the first 30 postoperative days. Elevated postoperative troponin levels were significantly associated with adverse cardiac events during the long-term surveillance period. The rates of cardiac-related and all-cause mortality were higher in patients with postoperative troponin elevation.</p><p><strong>Conclusion: </strong>Troponin measurement could be helpful in the prediction of adverse cardiac events. The predictive role of preoperative troponin, the patient population in whom routine troponin sampling should be used, and a comparison of different treatment methods/anesthesia techniques in carotid patients should be further examined.Clinical ImpactThe present scoping review critically appraises the extent and nature of the existing literature data on the predictive value of troponin on the occurrence of cardiac complications in patients undergoing CEA and CAS. In particular, it provides clinicians with essential insights by systematically summarizing the core evidence and identifying knowledge gaps that may direct future research. This, in turn, may significantly alter the current clinical practice and perhaps even reduce the incidence of cardiac complications in patients undergoing CEA/CAS.</p>","PeriodicalId":50210,"journal":{"name":"Journal of Endovascular Therapy","volume":" ","pages":"322-331"},"PeriodicalIF":1.7000,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Endovascular Therapy","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/15266028231179874","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/6/7 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"PERIPHERAL VASCULAR DISEASE","Score":null,"Total":0}
引用次数: 0
Abstract
Purpose: Patients undergoing carotid endarterectomy (CEA) or carotid artery stenting (CAS) are at substantially increased risk of short-term and long-term cardiac complications. Still, the role of perioperative troponin in predicting cardiac events remains unclear. The objective was to systematically summarize the existing evidence on the topic and provide directions for further research.
Materials and methods: Studies that examined perioperative troponin values and its association with myocardial injury, and/or myocardial infarction (MI), and/or major adverse cardiac events (MACE) and postoperative mortality in exclusively CEA/CAS patients, published in English until March 15, 2022, were retrieved through a systematic search of MEDLINE and Web of Science. The study selection process was independently performed by 2 authors, while the third researcher resolved disagreements.
Results: Four studies with 885 participants met the inclusion criteria. Age, chronic kidney disease, presentation of carotid disease, type of closure (primary closure/venous patch/Dacron/polytetrafluoroethylene patch), coronary artery disease, chronic heart failure, and the long-term use of calcium channel blockers represent risk factors for troponin elevation, which occurred in 11% to 15.3%. Myocardial infarction and MACE occurred in 23.5% to 40%, that is, 26.5% of patients with troponin elevation, respectively, during the first 30 postoperative days. Elevated postoperative troponin levels were significantly associated with adverse cardiac events during the long-term surveillance period. The rates of cardiac-related and all-cause mortality were higher in patients with postoperative troponin elevation.
Conclusion: Troponin measurement could be helpful in the prediction of adverse cardiac events. The predictive role of preoperative troponin, the patient population in whom routine troponin sampling should be used, and a comparison of different treatment methods/anesthesia techniques in carotid patients should be further examined.Clinical ImpactThe present scoping review critically appraises the extent and nature of the existing literature data on the predictive value of troponin on the occurrence of cardiac complications in patients undergoing CEA and CAS. In particular, it provides clinicians with essential insights by systematically summarizing the core evidence and identifying knowledge gaps that may direct future research. This, in turn, may significantly alter the current clinical practice and perhaps even reduce the incidence of cardiac complications in patients undergoing CEA/CAS.
目的:接受颈动脉内膜切除术(CEA)或颈动脉支架植入术(CAS)的患者发生短期和长期心脏并发症的风险显著增加。尽管如此,围手术期肌钙蛋白在预测心脏事件中的作用仍不清楚。目的是系统地总结关于该主题的现有证据,并为进一步研究提供方向。材料和方法:通过MEDLINE和Web of Science的系统检索,检索到截至2022年3月15日的英文发表的关于CEA/CAS患者围手术期肌钙蛋白值及其与心肌损伤、和/或心肌梗死(MI)、和/或主要心脏不良事件(MACE)和术后死亡率的研究。研究选择过程由两位作者独立完成,而第三位研究者解决分歧。结果:4项研究共885名受试者符合纳入标准。年龄、慢性肾脏疾病、颈动脉疾病的表现、闭合类型(原发性闭合/静脉补片/涤纶/聚四氟乙烯补片)、冠状动脉疾病、慢性心力衰竭和长期使用钙通道阻滞剂是肌钙蛋白升高的危险因素,发生率为11%至15.3%。术后前30天心肌梗死和MACE发生率分别为23.5% ~ 40%,即肌钙蛋白升高患者的26.5%。在长期监测期间,术后肌钙蛋白水平升高与心脏不良事件显著相关。术后肌钙蛋白升高患者的心脏相关死亡率和全因死亡率更高。结论:肌钙蛋白测定有助于心脏不良事件的预测。术前肌钙蛋白的预测作用,需要常规肌钙蛋白取样的患者人群,以及颈动脉患者不同治疗方法/麻醉技术的比较,有待进一步研究。临床影响:本综述批判性地评价了肌钙蛋白对CEA和CAS患者心脏并发症发生的预测价值的现有文献数据的范围和性质。特别是,它通过系统地总结核心证据和确定可能指导未来研究的知识差距,为临床医生提供了必要的见解。反过来,这可能会显著改变目前的临床实践,甚至可能降低CEA/CAS患者心脏并发症的发生率。
期刊介绍:
The Journal of Endovascular Therapy (formerly the Journal of Endovascular Surgery) was established in 1994 as a forum for all physicians, scientists, and allied healthcare professionals who are engaged or interested in peripheral endovascular techniques and technology. An official publication of the International Society of Endovascular Specialists (ISEVS), the Journal of Endovascular Therapy publishes peer-reviewed articles of interest to clinicians and researchers in the field of peripheral endovascular interventions.